DK0517787T3 - Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide - Google Patents

Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide

Info

Publication number
DK0517787T3
DK0517787T3 DK91905529T DK91905529T DK0517787T3 DK 0517787 T3 DK0517787 T3 DK 0517787T3 DK 91905529 T DK91905529 T DK 91905529T DK 91905529 T DK91905529 T DK 91905529T DK 0517787 T3 DK0517787 T3 DK 0517787T3
Authority
DK
Denmark
Prior art keywords
amperozide
resistant schizophrenia
therapy
treating
treating therapy
Prior art date
Application number
DK91905529T
Other languages
English (en)
Inventor
Anders Bjirk
Original Assignee
Pharmacia & Upjohn Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia & Upjohn Ab filed Critical Pharmacia & Upjohn Ab
Application granted granted Critical
Publication of DK0517787T3 publication Critical patent/DK0517787T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK91905529T 1990-03-01 1991-02-27 Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide DK0517787T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/487,547 US5013735A (en) 1990-03-01 1990-03-01 Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide
PCT/SE1991/000161 WO1991012805A1 (en) 1990-03-01 1991-02-27 Method of treating therapy-resistant schizophrenia with amperozide

Publications (1)

Publication Number Publication Date
DK0517787T3 true DK0517787T3 (da) 1999-04-06

Family

ID=23936183

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91905529T DK0517787T3 (da) 1990-03-01 1991-02-27 Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide

Country Status (8)

Country Link
US (1) US5013735A (da)
EP (1) EP0517787B1 (da)
JP (1) JP3243514B2 (da)
AT (1) ATE167398T1 (da)
DE (1) DE69129623T2 (da)
DK (1) DK0517787T3 (da)
ES (1) ES2117008T3 (da)
WO (1) WO1991012805A1 (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300422A (en) * 1991-12-04 1994-04-05 Case Western Reserve University Screening method for controlling agranulocytosis
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
US20080076924A1 (en) * 2006-06-30 2008-03-27 Patrick Betschmann Piperazines as P2X7 antagonists
US20080139573A1 (en) * 2006-12-08 2008-06-12 Copharm Treatment of resistant Schizophrenia and other CNS disorders
JP7321114B2 (ja) * 2019-04-26 2023-08-04 ユニ・チャーム株式会社 吸収性物品用の流動体の配置方法及び吸収性物品

Also Published As

Publication number Publication date
US5013735A (en) 1991-05-07
WO1991012805A1 (en) 1991-09-05
EP0517787A1 (en) 1992-12-16
JP3243514B2 (ja) 2002-01-07
DE69129623T2 (de) 1998-12-17
ATE167398T1 (de) 1998-07-15
DE69129623D1 (de) 1998-07-23
ES2117008T3 (es) 1998-08-01
JPH05504957A (ja) 1993-07-29
EP0517787B1 (en) 1998-06-17

Similar Documents

Publication Publication Date Title
LU91271I2 (fr) Natalizumab et ses dérivés pharmaceutiquement acceptables (TYSABRI)
DE69112717D1 (de) Neue Verwendung von Modafinil.
DK0758904T3 (da) Fremgangsmåder og sammensætninger til behandling af glomerulonephritis
IN172468B (da)
DK0665013T3 (da) Behandling af hyperproliferative karsygdomme
DK162770C (da) Analogifremgangsmaade til fremstilling af 3,20-dioxo-1,4-pregnadien-17alfa-ol-17-heteroaromatiske carboxylater
DK158723C (da) Analogifremgangsmaade til fremstilling af triphenylimidazol-2-yloxyalkansyrer og derivater deraf
FI953899A (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
DK472182A (da) Fremgangsmaade til fremstilling af et praeparat til behandling af urinvejsinfektioner
DK0714394T3 (da) Antipsykotisk fremgangsmåde
DK241287A (da) Anvendelse af glutamin til fremstilling af et laegemiddel til behandling af kataboliske forstyrrelser
DK0467564T3 (da) Behandling af inflammatoriske sygdomme med 15-ketoprostaglandinforbindelser
DK158496C (da) Middel til behandling af saar
DK0517787T3 (da) Fremgangsmåde til behandling af terapiresistent skizofreni med amperozide
DK0721453T3 (da) Fremgangsmåde til fremstilling af N-methyl-3-(1-methyl-4-piperidinyl)-14-indol-5-ethansulfonamid
DK361282A (da) Fremgangsmaade til fremstilling af o-alkyl-o-carbamoylglycerophosphocholiner
NO913117D0 (no) Fremgangsmaate for behandling av benoedeleggende sykdommer.
DK0588873T3 (da) Behandling af levercancer
DK0554691T3 (da) Fremgangsmåde til behandling af røggas
FR2514006B1 (da)
FI102173B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten heksahydrobents[CD]indolien valmistamiseksi
DK0469782T3 (da) Behandling af katarakt med prostacyclinforbindelser
FI931669A0 (fi) Foerfarande foer framstaellning av i form gjutna skodon av olika bredd
RO82920A (ro) Compozitie pentru tratarea fibrelor de sticla
DK36984D0 (da) Apparat til behandling af ar